ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

DVAX Dynavax Technologies Corp

11.01
-0.16 (-1.43%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Dynavax Technologies Corp DVAX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.16 -1.43% 11.01 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
11.11 11.03 11.26 11.21 11.17
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202415:05PRNUSDynavax to Report First Quarter 2024 Financial Results and..
04/3/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202419:17EDGAR2Form 144 - Report of proposed sale of securities
27/2/202417:54PRNUSDynavax to Present at TD Cowen's 44th Annual Health Care..
22/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202415:01PRNUSDynavax Reports Fourth Quarter and Full Year 2023 Financial..
20/2/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202407:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:15PRNUSDynavax to Report Fourth Quarter and Full Year 2023..
07/2/202419:41EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/2/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202413:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202409:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202408:05EDGAR2Form 8-K - Current report
08/1/202408:00PRNUSDynavax Announces Preliminary Unaudited Fourth Quarter and..
04/1/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202416:49EDGAR2Form 144 - Report of proposed sale of securities
03/1/202417:33PRNUSDynavax to Present at the 42nd Annual J.P. Morgan Healthcare..
02/1/202415:58EDGAR2Form 144 - Report of proposed sale of securities
05/12/202318:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:18EDGAR2Form 144 - Report of proposed sale of securities
20/11/202316:04PRNUSDynavax to Present at the 6th Annual Evercore ISI HealthCONx..
17/11/202316:28EDGAR2Form 144 - Report of proposed sale of securities
07/11/202316:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:26EDGAR2Form 144 - Report of proposed sale of securities
02/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202315:10EDGAR2Form 8-K - Current report
02/11/202315:01PRNUSDynavax Reports Third Quarter 2023 Financial Results and..
01/11/202315:49EDGAR2Form 144 - Report of proposed sale of securities
26/10/202315:15PRNUSDynavax to Report Third Quarter 2023 Financial Results and..
24/10/202317:14EDGAR2Form 144 - Report of proposed sale of securities
24/10/202317:10EDGAR2Form 144 - Report of proposed sale of securities
19/10/202312:15PRNUSDynavax to Present at the H.C. Wainwright 4th Annual..
11/10/202319:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:54EDGAR2Form 144 - Report of proposed sale of securities
10/10/202316:47EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

Delayed Upgrade Clock